Mauna Kea Technologies Announces Strongest Scientific Exposure Ever With More Than 40 Communications on Cellvizio® at Digestive Disease Week 2013
5/17/2013 10:59:30 AM
More...
|
FDA Clears Mauna Kea Technologies, Inc. (Formerly known as Cellvizio Inc.)'s AQ-Flex™ 19 Miniprobe
4/30/2013 9:07:24 AM
More...
|
Mauna Kea Technologies Announces Highlights of 5th Annual International Conference of Cellvizio® Users (ICCU)
4/24/2013 11:02:37 AM
More...
|
Mauna Kea Technologies Reports First Quarter 2013 Sales Up 11% to EUR 1.8 Million
4/16/2013 10:40:52 AM
More...
|
Mauna Kea Technologies Reports First Sale of Cellvizio® in China to Renowned Chinese Optical Biopsy Pioneer
4/10/2013 12:05:38 PM
More...
|
Mauna Kea Technologies Reports Full-Year 2012 Results in Line With Expectations
3/27/2013 10:28:46 AM
More...
|
Leading U.S. Pulmonologists to Investigate Impact of Mauna Kea Technologies' Cellvizio on Lung Cancer Diagnosis
3/22/2013 9:08:56 AM
More...
|
Mauna Kea Technologies Announces New Study Shows Optical Biopsy Is More Accurate Than Conventional Endoscopic Biopsy in Detecting Stomach Cancer
3/14/2013 9:48:59 AM
More...
|
Mauna Kea Technologies, Inc. (Formerly known as Cellvizio Inc.) Reports First Cellvizio® System Sales in Japan and New Clinical Research on Digestive Cancers and Disorders
1/30/2013 9:34:21 AM
More...
|
Mauna Kea Technologies, Inc. (Formerly known as Cellvizio Inc.) Announces 76% Increase in Full Year 2012 Sales and Record Sales of EUR 3.2 Million in the Fourth Quarter
1/15/2013 11:14:28 AM
More...
|
|